Statement Regarding Margaret Hamburg, M.D., stepping down as FDA Commissioner

Related posts:

1. Statement on FDA’s Proposed Oversight of Laboratory-Developed Tests A statement on the announcement by the Food and Drug Administration (FDA) that it plans to take steps to improve the oversight of laboratory-developed tests (LDTs)....
2. Fixing problems with cell lines Dr. Collins and NIGMS Director Dr. Jon Lorsch author an article in Science Magazine addressing cell line misidentification in research and suggesting best practices for authentication and verification. Science Magazine. December 19, 2014....
3. Exceptional Opportunities in Medical Science In a JAMA Viewpoint, Dr. Collins highlights areas of research showing great promise for advancing biomedical research and technology, treatments and therapies, and improving human health. JAMA. January 13, 2015. Volume 313, Number 2....
4. Dr. Collins is the guest lecturer at the MIT Compton Lecture At the MIT Compton Lecture, Dr. Collins talks about supporting and translating basic science into better treatments, and gives a tribute to researchers in Africa dedicated to studying Ebola....
5. Dr. Collins at the Economic Club of Washington, D.C. Topics ranging from genetic sequencing to biomedical research's economic impact....